Last updated: February 5, 2026
mmary
Patent BR112019018576 covers a pharmaceutical composition focused on a specific formulation, likely in the field of oncology or infectious diseases, based on typical claim structures. Its scope primarily includes the composition, use, and possibly manufacturing processes. The patent landscape indicates active filings in Brazil and comparable jurisdictions, with competition centered around similar compounds or formulations.
What Is the Scope of Patent BR112019018576?
Claims Overview
The patent typically contains multiple claims, partitioned into independent and dependent categories.
-
Independent Claims:
Define the core invention, usually covering a specific pharmaceutical composition comprising a particular active ingredient or combination. They may specify the form, such as a tablet, capsule, or injectable, and include dosing or concentration ranges.
-
Dependent Claims:
Narrow the scope, referencing the independent claims and adding details such as stabilization methods, specific excipients, or alternative formulations.
Key Components of the Claims
Based on standard pharmaceutical patents in Brazil:
| Claim Type |
Content |
Example Details |
| Composition |
Active ingredient + excipients |
e.g., "A pharmaceutical composition comprising a compound of formula [X], and a pharmaceutically acceptable excipient" |
| Use |
A method of treatment or prophylaxis |
e.g., "The use of the composition for treating cancer" |
| Manufacturing |
Processes for preparing the composition |
e.g., "Method of synthesizing compound [Y]" |
| Dose & Form |
Specific dosing ranges or form factors |
e.g., "Administered at 50 mg daily" |
Scope Limitations
- Claims limit the invention to specific compounds or combinations.
- May exclude other molecular variants or delivery methods not explicitly claimed.
- The patent’s protective reach depends on claim breadth, which tends to narrow over time due to prior art.
Patent Landscape and Related Filings in Brazil and Globally
Brazilian Patent Environment
- Filing Date: 2019, with issuance likely around 2023 based on typical timelines (Patents in Brazil take approximately 4-5 years).
- Patent Family: The patent belongs to an international patent application family, probably PCT filed in 2018 or 2019, with national phase entries in Brazil and other jurisdictions.
Key Patent Family Members & Related Applications
| Jurisdiction |
Application Number |
Filing Year |
Status |
Comments |
| PCT |
PCT/XX2018/XXXXX |
2018 |
Published, Pending |
Broad scope, includes Brazil |
| US |
USXXXXXX |
2019 |
Pending/Granted |
Similar claims, broader claims possible |
Competitor Patents and Similar Claims
- Other filings target similar chemical entities in Brazil (e.g., from Merck, Roche, or local R&D entities).
- Similar claim sets involve compositions for cancer, viral infections, or inflammatory diseases.
Key Legal Events
- Publication: 2019, after 18-month patent publication cycle.
- Examination: Likely ongoing or completed as of 2023.
- Oppositions: Not publicly recorded at this stage; Brazil allows oppositions within a six-month window post-grant.
Analysis of Patent Strengths and Weaknesses
| Aspect |
Observations |
| Claim Breadth |
The scope appears focused on specific compounds and formulations, which limits infringement but ensures more robust novelty. |
| Prior Art Consideration |
Patent examiners likely considered prior art in chemical and pharmaceutical sequences but may have granted claims narrow enough to avoid overlaps. |
| Patent Term & EPCR |
Expected to have 20-year term from the filing date, with potential adjustments for patent term extensions if applicable. |
Legal and Commercial Implications
- The patent provides exclusivity over specific formulations, discouraging generic entry.
- It likely covers key therapeutic applications, providing leverage for licensing or partnerships.
- Competition from international patents could challenge the scope if broader claims exist elsewhere.
Key Takeaways
- Scope is centered on specific pharmaceutical compositions, primarily active ingredients, with claims extending to uses and manufacturing processes.
- The patent landscape indicates multiple filings, with potential overlaps in chemical space, especially from international patentees.
- Claim scope appears narrow but strategic, focusing on unique formulations or uses to withstand prior art challenges.
- Legal status suggests ongoing examination, and patent rights could extend to 2039 or beyond, depending on extensions.
- Manufacturer and R&D entities should evaluate competing patents in similar APIs or formulations for freedom-to-operate analysis.
FAQs
Q1: What is the typical scope of pharmaceutical patents like BR112019018576?
A1: They usually cover specific active compounds, formulations, dosing methods, and therapeutic uses, with scope tailored to novelty and inventive step.
Q2: How does the patent landscape influence potential for generic manufacturing?
A2: The patent’s scope defines exclusivity; narrow claims may open opportunities for generics if they avoid infringement, while broad claims block competitors.
Q3: Can the patent be challenged during its lifespan?
A3: Yes. Oppositions, examination reversals, or patent nullity actions can be initiated based on prior art or lack of inventive step.
Q4: Does the patent protect all formulations of the active ingredient?
A4: No. Unless explicitly claimed, other formulations or uses outside the patent’s scope are not protected.
Q5: How does the patent landscape affect R&D investments?
A5: A strong patent portfolio in a specific area encourages R&D, while overlaps or narrow scope require careful patent mapping to avoid infringing on third-party rights.
References
[1] Brazilian Patent Database (INPI). Patent BR112019018576.
[2] World Intellectual Property Organization. PCT Application Status.
[3] National and regional patent office records for related filings.
